AMLX
#1661
Amylyx Pharmaceuticals, Inc. - Common Stock
26.8 5 USD
-0.02%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-2.29%
Variación mensual
-19.18%
Variación en los últimos 6 meses
+58.59%
Cambio anual
+83.90%
Cierres anteriores
27.4 8
Open
27.4 9
Mínimo
26.8 0
Máximo
27.6 9
Financials
- Market Capitalization 2.99 B
- Employee 136
- Founded 2013
- CEO N/A
- Website www.amylyx.com
- Headquarter Delaware, United States
- FIGI BBG00DP10YT5
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-7.9
Relación precio/flujo de caja
—
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1625 |  TARS Tarsus Pharmaceuticals, Inc. - Common Stock | 70.82 USD | -4.81% | -3.75% | -11.13% | +7.21% | 3.11 B USD | ||
| 1629 |  CELC Celcuity Inc. - Common Stock | 63.19 USD | -4.04% | -10.39% | -24.46% | +34.82% | 3.09 B USD | ||
| 1676 |  DNLI Denali Therapeutics Inc. - Common Stock | 18.40 USD | -2.90% | -2.90% | -12.75% | +13.79% | 2.94 B USD | ||
| 1690 |  ELVN Enliven Therapeutics, Inc. - Common Stock | 39.49 USD | -3.31% | -5.12% | -28.20% | +91.14% | 2.89 B USD |